| Ms Karen Ann Little, MSPT | |
|
160 E Main St, Port Jervis, NY 12771-2114 | |
| (845) 858-7000 | |
| Not Available |
| Full Name | Ms Karen Ann Little |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 160 E Main St, Port Jervis, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366567182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 13401-1 (New York) | Primary |
| 225100000X | Physical Therapist | PT019472 (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karen Ann Little, MSPT 108 Old Cahoonzie Road, Sparrow Bush, NY 12780-5556 Ph: (845) 858-7000 | Ms Karen Ann Little, MSPT 160 E Main St, Port Jervis, NY 12771-2114 Ph: (845) 858-7000 |
News Archive
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Cancer patients with blood clots - which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients - gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting.
Sonomax Hearing Healthcare Inc. is pleased to announce that it has signed a five year license agreement with Hearing Coach Africa (Pty). The agreement for V3 hearing protectors specifies quarterly commitments over five years, totaling a minimum of $1,000,000. The agreement is renewable for an additional 5 years if all contractual conditions and minimum quarterly commitments are met.
› Verified 7 days ago
Jessica Velez, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 160 E Main St, Port Jervis, NY 12771 Phone: 845-858-7000 | |
Miss Jocelyn Pidal Tanty, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 160 East Main Street, Genesis - Bon Secours Community Hospital/st. Josephs, Port Jervis, NY 12771 Phone: 845-858-7000 | |
Dominic James Costantino, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 17 Franklin Street, Port Jervis, NY 12771 Phone: 718-877-2907 | |
Mr. Michael Thomas Carroll, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 Oak St, Port Jervis, NY 12771 Phone: 845-856-1639 | |
Gincy Thomas, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 181 Jersey Ave, Port Jervis, NY 12771 Phone: 845-858-9999 Fax: 845-858-9998 | |
Kristin E Banse, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 181 Jersey Avenue, Port Jervis, NY 12771 Phone: 845-858-9999 Fax: 845-858-9998 |